Base Year
Historical Year
Forecast Year
The global viral inactivation market size was valued at USD 686.62 million in 2023, driven by rising prevalence of chronic diseases such as cancer, autoimmune disorders, and other diseases, and rising healthcare expenditures. The market is estimated to grow at a CAGR of 11.5% during the forecast period 2024-2032 to attain a value of USD 1,828.89 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to account for a considerable share of the viral inactivation industry. This can be attributed to the robust healthcare infrastructure, and the presence of large pharmaceutical and biopharmaceutical companies. The increasing healthcare research and development (R&D) spending by the United States government is expected to fuel the market in North America. The robust growth of the pharmaceuticals industry, the surging approvals of novel drugs, and the rising penetration of research and academic institutes that promote biotechnology and life science research activities are projected to boost the growth of the viral inactivation industry. Moreover, the increasing use of technologically advanced processes for the production of new and novel drugs is anticipated to bolster the market for viral inactivation in the forecast period.
The viral inactivation industry in Europe is witnessing robust growth due to the increasing spending on research and development (R&D) activities and new product releases in the life sciences industry. Meanwhile, due to the expanding healthcare infrastructure, the Asia Pacific region is predicted to grow rapidly. The increasing prevalence of chronic diseases in developing economies like India and China and the growing interests in life sciences and biotechnology research activities are estimated to invigorate the viral inactivation industry in the coming years.
Viral inactivation is a method of viral elimination in which the viruses are removed but remain non-infectious in the finished product. The inactivation of viruses is a crucial step in the viral clearance process. Viral inactivation is integral in the manufacturing of biological goods such as tissue and tissue products, stem cell products, vaccines and medicines, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
The significant applications of viral inactivation are:
The various end-uses of viral inactivation in the market are:
The EMR report looks into the regional markets of viral inactivation like into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rising prevalence of chronic diseases such as cancer, autoimmune disorders, and other diseases, and rising healthcare expenditures are driving the viral inactivation industry. The market is also being propelled by the rapid growth of the pharmaceutical and biotechnology industries, and the increasing launches of novel medication. Various governments are increasingly introducing favourable initiatives to support and fund viral inactivation research activities to prevent viral outbreaks, especially in the wake of the COVID-19 pandemic. With the growing concerns regarding the transmission of blood-borne viruses through plasma-derived medical goods, the demand for effective viral inactivation is significantly surging and driving the market growth.
The increasing investments in research and development (R&D) activities for the development of innovative therapeutics in the life science industry is leading to a surge in the use of kits and reagents, which is invigorating the market growth. Advancements in nano filtration technology are surging the demand for viral inactivation for efficient viral elimination in the manufacturing of biopharmaceutical drugs, therefore adding to the market growth. Furthermore, the increased research and development (R&D) activities for innovations in stem cell and cellular and gene therapy are expected to provide lucrative growth opportunities for the market expansion in the forecast period.
The report gives a detailed analysis of the following key players in the global viral inactivation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End-user |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global market for viral inactivation reached a value of USD 686.62 million in 2023.
The market is anticipated to grow at a CAGR of 11.5% during the forecast period of 2024-2032 to reach a value of USD 1,828.89 million by 2032.
The market is being driven by the increasing approvals of novel drugs, the surging use of technologically advanced processes in development of new drugs, and the robust growth of the healthcare industry.
The growing prevalence of chronic diseases, the rapid growth of the biotechnology and life sciences industry, and advancements in nano filtration technology are projected to propel the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of viral inactivation are kits and reagents, systems, and services.
The significant applications of viral inactivation in the market are vaccines and therapeutics, stem cell products, blood and blood products, tissue and tissue products, and cellular and gene therapy.
The various end-uses in the market are pharmaceutical and biotechnology companies, CROs, and academic and research institutes, among others.
The major players in the industry are Rad Source Technologies Inc, Merck KGaA, Parker Hannifin Corp, Sartorius AG, Cerus Corporation, Cytiva (Danaher Corporation), Charles River Laboratories, CONVATEC GROUP PLC, WuXi AppTec, TERUMO BCT, INC., Thermo Fisher Scientific Inc., and SCI Automation, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share